Cargando…
Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer
OBJECTIVE: To investigate the clinical efficacy and safety of albumin paclitaxel combined with intrapleural bevacizumab + lobaplatin for patients with non-squamous non-small cell lung cancer (NS-NSCLC) with malignant pleural effusion (MPE) and analyze prognostic factors. METHODS: A total of 126 NS-N...
Autores principales: | Hou, Junjie, Mi, Xuguang, Liu, Ning, Yang, Ying, Qi, Zhaoxue, Li, Xiaonan, Lu, Xiaodan, Jiang, Xianzhuo, Yu, Yingying, Zhou, Ying, Ni, Zhiqiang, Fang, Yanqiu, Jin, Ningyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251141/ https://www.ncbi.nlm.nih.gov/pubmed/35794989 http://dx.doi.org/10.1155/2022/5901450 |
Ejemplares similares
-
Intrapleural combination therapy with lobaplatin and erythromycin for non‐small cell lung cancer‐mediated malignant pleural effusion
por: Xu, Lisheng, et al.
Publicado: (2018) -
Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis
por: Cheng, Xingzhen, et al.
Publicado: (2022) -
Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer
por: Yan, Mao-Hui, et al.
Publicado: (2021) -
A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer
por: Nie, Keke, et al.
Publicado: (2019) -
Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018)